C07D 249/12
Oxygen or sulfur atoms
C07D249/12 (Oxygen or sulfur atoms) appears on 1,115 US grants and 711 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,115
- Published applications
- 711
- Assignees
- 405
- Inventors
- 2,522
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 19 | 0 |
| 1978 | 23 | 0 |
| 1979 | 22 | 0 |
| 1980 | 19 | 0 |
| 1981 | 29 | 0 |
| 1982 | 19 | 0 |
| 1983 | 22 | 0 |
| 1984 | 15 | 0 |
| 1985 | 8 | 0 |
| 1986 | 16 | 0 |
| 1987 | 5 | 0 |
| 1988 | 12 | 0 |
| 1989 | 14 | 0 |
| 1990 | 28 | 0 |
| 1991 | 23 | 0 |
| 1992 | 23 | 0 |
| 1993 | 32 | 0 |
| 1994 | 22 | 0 |
| 1995 | 26 | 0 |
| 1996 | 27 | 0 |
| 1997 | 29 | 0 |
| 1998 | 26 | 0 |
| 1999 | 27 | 0 |
| 2000 | 27 | 0 |
| 2001 | 37 | 6 |
| 2002 | 34 | 21 |
| 2003 | 29 | 32 |
| 2004 | 16 | 37 |
| 2005 | 21 | 31 |
| 2006 | 20 | 29 |
| 2007 | 14 | 26 |
| 2008 | 10 | 27 |
| 2009 | 17 | 29 |
| 2010 | 20 | 30 |
| 2011 | 21 | 34 |
| 2012 | 29 | 32 |
| 2013 | 30 | 37 |
| 2014 | 21 | 36 |
| 2015 | 31 | 32 |
| 2016 | 23 | 27 |
| 2017 | 22 | 27 |
| 2018 | 24 | 34 |
| 2019 | 23 | 34 |
| 2020 | 32 | 35 |
| 2021 | 30 | 31 |
| 2022 | 15 | 23 |
| 2023 | 21 | 22 |
| 2024 | 19 | 19 |
| 2025 | 11 | 11 |
| 2026 | 10 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Agrochemical composition11 Aug 2026US 12,702,133 B2Upl Ltd
- Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition16 Jun 2026US 12,653,809 B2Nurix Therapeutics, Inc.
- [(5-phenyl-1-heteroaryl-1H-triazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants5 May 2026US 12,617,760 B2Bayer Aktiengesellschaft
- Triazolone compound21 Apr 2026US 12,606,540 B2Medshine Discovery Inc.
- Substituted 1,2,4-triazoles and methods of use14 Apr 2026US 12,600,704 B2Stinginn LLC
- Novel compounds6 Aug 2026US 2026/0226031 A1NRG Therapeutics Ltd
- Compounds, compositions and uses thereof in the treatment and prevention of diseases and conditions associate with or aggravated by impaired mitophagy or oxidative stress30 Jul 2026US 2026/0217659 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Compounds as modulators of stat6 and uses thereof18 Jun 2026US 2026/0166047 A1Amgen Inc.
- Process for the preparation of a chiral pyrrolo triazole alcohol11 Jun 2026US 2026/0159522 A1Hoffmann-La Roche Inc.
- Bromine- or iodine-para-substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy]acetic acid derivatives and their salts, agents for protecting useful plants or crop plants comprising them, methods for producing them and their use as safeners28 May 2026US 2026/0144252 A1Bayer Aktiengesellschaft
Most cited
By later US patents
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003
- Sulphonylaminocarbonyltriazolinones105US 5,625,074 ABayer Aktiengesellschaft · 1997
- Substituted 5-alkoxy-1,2,4-triazol-3-(THI) ones104US 5,652,372 ABayer Aktiengesellschaft · 1997
- Intermediates for herbicidal sulphonyl-aminocarbonlyltriazolinones having substituents which are bonded via sulphur99US 5,750,718 ABayer Aktiengesellschaft · 1998
- Pharmacologically active guanidine compounds97US 3,950,333 ASmith Kline & French Laboratories Limited · 1976